| CANDRIAM EQUITIES L AUSTRALIA C CAP AUD | RVI AUSTRALIA | 5,71% | 9,59% | 44,80% | 131,19% |
| CANDRIAM EQUITIES L AUSTRALIA C CAP EUR | RVI AUSTRALIA | 5,50% | 9,56% | 44,19% | 130,45% |
| CANDRIAM EQUITIES L AUSTRALIA C DIS AUD | RVI AUSTRALIA | 1,59% | -1,54% | 22,14% | 65,65% |
| CANDRIAM EQUITIES L AUSTRALIA C-H CAP USD | RVI AUSTRALIA | -4,78% | · | · | · |
| CANDRIAM EQUITIES L AUSTRALIA I CAP AUD | RVI AUSTRALIA | 6,92% | 13,41% | 53,29% | 158,51% |
| CANDRIAM EQUITIES L AUSTRALIA I CAP EUR | RVI AUSTRALIA | 6,71% | 13,36% | 52,71% | 158,43% |
| CANDRIAM EQUITIES L AUSTRALIA N CAP AUD | RVI AUSTRALIA | 5,23% | 8,10% | 41,53% | 120,61% |
| CANDRIAM EQUITIES L AUSTRALIA N CAP EUR | RVI AUSTRALIA | 5,02% | 8,06% | 41,00% | 120,50% |
| CANDRIAM EQUITIES L AUSTRALIA R CAP AUD | RVI AUSTRALIA | 6,66% | 12,56% | 51,37% | 151,48% |
| CANDRIAM EQUITIES L AUSTRALIA V CAP AUD | RVI AUSTRALIA | 7,16% | 14,09% | 54,68% | · |
| CANDRIAM EQUITIES L BIOTECHNOLOGY C CAP EUR | BIOTECNOLOGÍA | 20,32% | 37,07% | 48,88% | 161,41% |
| CANDRIAM EQUITIES L BIOTECHNOLOGY C CAP USD | BIOTECNOLOGÍA | 20,05% | 37,25% | 48,50% | 161,36% |
| CANDRIAM EQUITIES L BIOTECHNOLOGY C DIS USD | BIOTECNOLOGÍA | 19,32% | 34,80% | 43,97% | 146,54% |
| CANDRIAM EQUITIES L BIOTECHNOLOGY C-H CAP EUR | BIOTECNOLOGÍA | 34,41% | 42,29% | 31,48% | 128,98% |
| CANDRIAM EQUITIES L BIOTECHNOLOGY I CAP EUR | BIOTECNOLOGÍA | 20,36% | 38,30% | 50,39% | 170,27% |
| CANDRIAM EQUITIES L BIOTECHNOLOGY I CAP USD | BIOTECNOLOGÍA | 20,07% | 38,29% | 49,64% | 168,17% |
| CANDRIAM EQUITIES L BIOTECHNOLOGY I-H CAP EUR | BIOTECNOLOGÍA | 34,52% | 42,50% | 32,62% | 139,62% |
| CANDRIAM EQUITIES L BIOTECHNOLOGY N CAP USD | BIOTECNOLOGÍA | 19,62% | 35,76% | 45,53% | 150,32% |
| CANDRIAM EQUITIES L BIOTECHNOLOGY R CAP EUR | BIOTECNOLOGÍA | 21,47% | 40,95% | 55,65% | · |
| CANDRIAM EQUITIES L BIOTECHNOLOGY R CAP USD | BIOTECNOLOGÍA | 21,12% | 40,94% | 54,88% | 183,52% |
